Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose Tolerability Study of Benapenem in Healthy Subjects
NCT03588156Phase 1Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Mar 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of benapenem in bacterial infection, sponsored by Sihuan Pharmaceutical. Primary endpoints: Number of subjects with clinically significant findings in vital signs at Day 4, Number of subjects with clinically significant findings in laboratory parameters at Day 4 and 1 more. Started Mar 2015; status: completed.
02
Drugs
benapenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03588156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03588156.